Charles River Laboratories Intl. Inc vs Victoria's Secret & Co — how do they compare? Charles River Laboratories Intl. Inc trades at $303.99 (market cap $14.23B), while Victoria's Secret & Co trades at $81.88 (market cap $6.91B). The key difference: Charles River Laboratories Intl. Inc is far larger — about 2.1× Victoria's Secret & Co's market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, Victoria's Secret & Co nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and Victoria's Secret & Co for 34 Days on average.
| CRL | VSXY | |
|---|---|---|
Market Cap | $14.23B | $6.91B |
Volume | 1,176,885 | 1,346,928 |
Sector | Health | Consumer Cyclical |
52-Week High | $310.77 | $99.97 |
52-Week Low | $149.93 | $28.25 |
Typical Hold Time | 33 Days | 34 Days |
Enterprise Value | $17.06B | $9.29B |
Signals from Pluang's Aura AI — not financial advice
CRL trades at $304.01, up 1.24% on the day, near the consensus price target of $305.50. The stock shows a bullish technical trend with strong analyst support (73% buy ratings) and has beaten EPS estimates for three consecutive quarters. However, fundamentals reveal challenges with negative net income margins and a high P/E ratio of 684.85, while recent news highlights a strategic growth plan targeting 5-7% revenue growth and $300 million in savings by 2030.
The outlook is cautiously optimistic given strong analyst sentiment and recent earnings beats, but high valuation and profitability concerns pose risks. Investment opportunity hinges on successful execution of the new growth strategy to improve margins, while key risks include persistent negative earnings, competitive pressures, and execution missteps in achieving long-term targets.
Victoria's Secret (VSXY) trades at $85.79, up 0.83% with a bullish technical signal and strong earnings beat history. The stock shows robust profitability with 45.27% ROE and 39.57% gross margins, though net margins remain modest at 5.47%. Recent news highlights fashion show expansion and global growth initiatives, with institutional buying supporting positive sentiment. The current price sits near the consensus target of $86.80, with support at $85 and resistance at $87.
VSXY presents a compelling growth story with accelerating fundamentals and analyst support, though rich valuation at 19.33 P/E and competitive retail pressures warrant caution. The 2026 outlook improvement and consistent earnings beats provide upside potential, while margin pressures and consumer spending volatility represent key risks for investors.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →Victoria's Secret & Co is a specialty retailer of lingerie, pajamas, and beauty products with prestige fragrances and body care. It serves customers at its Lingerie and Beauty stores around the globe and online enabling them to shop the brand anywhere and anytime.
Read more on VSXY →